<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="HCE53B84536614B11BCF8E0D5EADF4635" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>119 HR 5178 IH: Sickle Cell Disease Comprehensive Care Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2025-09-08</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">119th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 5178</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20250908">September 8, 2025</action-date><action-desc><sponsor name-id="D000628">Mr. Dunn of Florida</sponsor> (for himself, <cosponsor name-id="D000096">Mr. Davis of Illinois</cosponsor>, <cosponsor name-id="C001103">Mr. Carter of Georgia</cosponsor>, <cosponsor name-id="F000481">Mr. Figures</cosponsor>, <cosponsor name-id="B001257">Mr. Bilirakis</cosponsor>, <cosponsor name-id="J000310">Ms. Johnson of Texas</cosponsor>, <cosponsor name-id="N000147">Ms. Norton</cosponsor>, <cosponsor name-id="M001229">Mrs. McIver</cosponsor>, <cosponsor name-id="F000110">Mr. Fields</cosponsor>, <cosponsor name-id="G000553">Mr. Green of Texas</cosponsor>, <cosponsor name-id="G000583">Mr. Gottheimer</cosponsor>, <cosponsor name-id="T000481">Ms. Tlaib</cosponsor>, <cosponsor name-id="J000288">Mr. Johnson of Georgia</cosponsor>, <cosponsor name-id="J000309">Mr. Jackson of Illinois</cosponsor>, <cosponsor name-id="D000230">Mr. Davis of North Carolina</cosponsor>, <cosponsor name-id="S001200">Mr. Soto</cosponsor>, <cosponsor name-id="B001315">Ms. Budzinski</cosponsor>, <cosponsor name-id="S001185">Ms. Sewell</cosponsor>, <cosponsor name-id="T000193">Mr. Thompson of Mississippi</cosponsor>, and <cosponsor name-id="M001196">Mr. Moulton</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend title XIX of the Social Security Act to enable State Medicaid programs to provide comprehensive, coordinated care through a health home to individuals with sickle cell disease.</official-title></form><legis-body id="HF6DD4903A1A14D73B261A0F1DB2B7B99" style="OLC"> 
<section section-type="section-one" id="H1DFD1CE9ADC947CF91007A3205C96659"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Sickle Cell Disease Comprehensive Care Act</short-title></quote>.</text></section> <section id="H39BA7862C9244ABC8E8DF3FA2A319560"><enum>2.</enum><header>Enabling State Medicaid programs to provide care through health homes to individuals with sickle cell disease</header><text display-inline="no-display-inline">Section 1945 of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1396w-4">42 U.S.C. 1396w–4</external-xref>) is amended—</text> 
<paragraph id="HC5343465540F415AA6EDB1697BDD60D5"><enum>(1)</enum><text>in subsection (a), by inserting <quote>(and, beginning January 1, 2026, to eligible individuals with sickle cell disease (as defined in subsection (c)(5)))</quote> after <quote>chronic conditions</quote>;</text></paragraph> <paragraph id="HEFCEE0D249D94B2B985A2CB2242EDA29"><enum>(2)</enum><text>in subsection (c)—</text> 
<subparagraph id="HF56D9BF656DF4891A4A6E21C16386B0A"><enum>(A)</enum><text>in paragraph (1), by inserting <quote>and each eligible individual with sickle cell disease</quote> after <quote>chronic conditions</quote>; and</text></subparagraph> <subparagraph id="H548DE1ABF2EB42889076681D3702D352"><enum>(B)</enum><text>by adding at the end the following new paragraph:</text> 
<quoted-block style="OLC" display-inline="no-display-inline" id="HFCC79425A5E048E4A665F861B5C35C07"> 
<paragraph id="H7CD0024D3D984C59999339EA24B3EAD1"><enum>(5)</enum><header>Special rule relating to sickle cell disease health homes</header> 
<subparagraph commented="no" display-inline="no-display-inline" id="H10572ACFB642407499DD5E40FA3737C6"><enum>(A)</enum><header>In general</header><text>Beginning January 1, 2026, the Secretary may approve a State plan amendment under this section that is designed to provide health home services primarily to eligible individuals with sickle cell disease (in this section referred to as a <term>sickle cell disease-focused State plan amendment</term>).</text></subparagraph> <subparagraph id="HF5E6B90C58164854BD00BB0BBBFA2563"><enum>(B)</enum><header>Requirement to provide dental and vision services</header><text>In the case of a sickle cell disease-focused State plan amendment approved by the Secretary on or after January 1, 2026, a State shall ensure the provision of dental and vision services to eligible individuals with sickle cell disease who are enrolled in such health home. Such requirement shall apply irrespective of existing requirements related to comparability or whether or not the State provides dental or vision services to other Medicaid beneficiaries. </text></subparagraph> 
<subparagraph id="HAB04A20999864E738ED0D2DA307F8285"><enum>(C)</enum><header>Report requirements</header> 
<clause commented="no" display-inline="no-display-inline" id="H9375729CC358413EABFDEE9263402B34"><enum>(i)</enum><header>In general</header><text display-inline="yes-display-inline">In the case of a State with a sickle cell disease-focused State plan amendment, such State shall, not later than the last day of the 8th fiscal year quarter that such State plan amendment is in effect, submit to the Secretary a report on the following, with respect to eligible individuals with sickle cell disease provided health home services under such State plan amendment:</text> <subclause id="H8690B544B2234D898764BCE359A2C2C7"><enum>(I)</enum><text>The quality of health care provided to such individuals, with a focus on outcomes relevant to the recovery of each such individual.</text></subclause> 
<subclause id="H72D3349AC42F410590137BC5839F4BBA"><enum>(II)</enum><text>The access of such individuals to health care.</text></subclause> <subclause id="H00AE8BCD5A574E218D8FA57FC929F0EF"><enum>(III)</enum><text>The total expenditures of such individuals for health care.</text></subclause></clause> 
<clause commented="no" display-inline="no-display-inline" id="H4FB222C5DD2B49B18CB0C3F8A380B71E"><enum>(ii)</enum><header>Applicable measures</header><text>For purposes of the report required under this subparagraph, the Secretary shall specify all applicable measures for determining quality of health care provided to eligible individuals with sickle cell disease, access to health care by such individuals, and expenditures on health care by such individuals.</text></clause></subparagraph> <subparagraph id="H8ADA4EA790C84E438D677AE299958B22"><enum>(D)</enum><header>Best practices</header><text>Not later than June 30, 2026, the Secretary shall make publicly available on the website of the Centers for Medicare &amp; Medicaid Services best practices for designing and implementing a sickle cell disease-focused State plan amendment, based on clinical practice guidelines for sickle cell disease developed by medical specialty societies and in consultation with sickle cell disease providers and patient advocacy organizations.</text></subparagraph> 
<subparagraph commented="no" display-inline="no-display-inline" id="HF989D1F3CD9A4F78ACC5115F2A118090"><enum>(E)</enum><header display-inline="yes-display-inline">Definitions</header><text>For purposes of this section:</text> <clause id="H80DB49B7C5C94BEDBAD1078ED0CD42E9"><enum>(i)</enum><header>Eligible individual with sickle cell disease</header><text>The term <term>eligible individual with sickle cell disease</term> means, with respect to a State, an individual who satisfies all of the following:</text> 
<subclause id="HDE6AA6EFBABB48138DBFB23CF7FCA787"><enum>(I)</enum><text>The individual is eligible for medical assistance under the State plan of such State or under a waiver of such plan.</text></subclause> <subclause id="H68085BF699164CAB8A5A3BC60289203C"><enum>(II)</enum><text>The individual has sickle cell disease.</text></subclause> 
<subclause id="H40F601F08BB245C0AC48BE5454F53F8A"><enum>(III)</enum><text>The individual may or may not have previously received health home services under any other State plan amendment approved for the State under this section by the Secretary.</text></subclause></clause> <clause id="H0ED18DCC897942248C9811FEBD53605A"><enum>(ii)</enum><header>Sickle cell disease</header><text>The term <term>sickle cell disease</term> means an inherited blood disorder affecting red blood cells that occurs when an individual has inherited a sickle cell gene from each parent, as identified by a newborn screening or other genetic test.</text></clause></subparagraph></paragraph><after-quoted-block>; and</after-quoted-block></quoted-block></subparagraph></paragraph> 
<paragraph commented="no" id="H9075B64FAC964C5784439FED7596BDA8"><enum>(3)</enum><text>in subsection (h)(5), by inserting <quote>or a health home for eligible individuals with sickle cell disease</quote> after <quote>chronic conditions</quote>.</text></paragraph></section> </legis-body></bill>

